Skip to main content
. 2018 Aug 31;7(8):525–533. doi: 10.1002/psp4.12309

Table 2.

Significant results from testing between genotypes for outcomes of pharmacokinetics

Outcome Direction P value Q value
Group 1 vs. group 3 (143E allele)
AUC d‐MPH Group 3 higher 0.000454 0.003630
Half‐life d‐MPH Group 3 higher 0.000982 0.007860
Cmax d‐MPH Group 3 higher 0.007112 0.056892

AUC, area under the curve; Cmax, peak plasma concentration; MPH, methylphenidate.